Physician profile
Sitara Kishore
NPI 1831551993
$991.53
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $130 · 2021: $664 · 2022: $147 · 2023: $35.34 · 2024: $15.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $50.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $50.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $318.28 | 2020-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $230.50 | 2021 | |
| Amgen INC. | $111.22 | 2021 | |
| Pfizer INC. | $57.29 | 2021-2022 | |
| Ucb, INC. | $48.84 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $47.22 | 2020-2023 | Camzyos |
| Gilead Sciences, INC. | $42.16 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.91 | 2021-2022 | |
| Melinta Therapeutics, LLC | $29.45 | 2021 | |
| Phadia US INC. | $16.14 | 2021 | |
| La Jolla Pharmaceutical Company | $15.18 | 2023 | Xerava |
| Nestle Healthcare Nutrition INC. | $14.78 | 2021 | |
| Paratek Pharmaceuticals, INC. | $12.63 | 2021 | |
| Penumbra, INC. | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sitara Kishore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.